New drug reduces cardiovascular events in patients with type 2 diabetes
Millions miss out on vital health checks that can help spot diabetes
Growing diabetes epidemic to trigger 'sharp rise' in heart attacks and strokes by 2035
Hepatitis C deaths fall by 11 percent but diagnosis of complications shows little improvement
Diabetes not taken seriously by UK public
Intense multifactorial treatment for type 2 diabetes shown to be cost effective
When patients with type 2 diabetes receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there is no significant increase in medical costs, compared to patients who receive conventional, multifactorial treatment, according to the study presented at the American Diabetes Association conference.